Correct Answer: A. Rebound hypertension
Clonidine is a central α₂-adrenergic agonist that suppresses sympathetic outflow and lowers blood pressure. During chronic use, the body adapts by upregulating α₂-adrenergic receptors and increasing sympathetic tone as a compensatory mechanism. When clonidine is abruptly discontinued, this compensatory sympathetic hyperactivity is unopposed, causing a sudden surge in catecholamine release and a marked increase in blood pressure—a phenomenon called rebound hypertension. This acute elevation in blood pressure manifests clinically as severe headache, palpitations, and anxiety, typically occurring within 12–48 hours of drug withdrawal. The headache is a direct consequence of the acute hypertensive crisis. This is a well-recognized and potentially dangerous adverse effect in Indian clinical practice, particularly in de-addiction programs where compliance may be poor. The key discriminator is that rebound hypertension is a consequence of abrupt withdrawal, not a direct pharmacological property of the drug itself. Gradual tapering of clonidine prevents this complication by allowing the sympathetic nervous system to readjust gradually.
Why the other options are wrong
B. Receptor upregulation — While receptor upregulation does occur during chronic clonidine therapy and is the mechanism underlying rebound hypertension, it is not itself the clinical condition causing the headache. Upregulation is a cellular adaptation process, not a pathological state. The question asks for the reason behind the condition (headache), which is the rebound hypertension that results from unopposed upregulated receptors—not the upregulation itself. C. Receptor hypersensitivity — Receptor hypersensitivity is a vague term and does not accurately describe the pharmacological mechanism. While upregulated receptors may be more responsive, the primary problem is not hypersensitivity but rather the unopposed sympathetic surge following withdrawal. This is a trap answer that confuses the mechanism with the clinical outcome. Hypersensitivity does not explain the acute hypertensive crisis. D. Postural hypotension — Postural hypotension (orthostatic hypotension) is actually a side effect of clonidine therapy itself, not a consequence of withdrawal. After abrupt discontinuation, blood pressure rises acutely due to rebound hypertension, not falls. This is a classic NBE trap: students may confuse the known side effect of clonidine (hypotension during therapy) with the withdrawal phenomenon (hypertension after stopping).
High-Yield Facts
- Clonidine withdrawal syndrome presents with rebound hypertension, headache, anxiety, and palpitations within 12–48 hours of abrupt discontinuation.
- α₂-agonist rebound hypertension occurs because chronic drug use causes compensatory upregulation of α₂-receptors and increased sympathetic tone; withdrawal removes the suppression, causing unopposed catecholamine surge.
- Gradual tapering (over 7–10 days) of clonidine prevents rebound hypertension by allowing sympathetic nervous system readjustment.
- Other α₂-agonists (methyldopa, doxazosin) can also cause rebound hypertension if stopped abruptly; this is a class effect.
- Rebound hypertension is a clinical emergency requiring reinitiation of the drug or use of alternative antihypertensives (β-blockers, vasodilators) to manage acute symptoms.
Mnemonics
CLONIDINE WITHDRAWAL = REBOUND Central α₂-agonist → Long-term use → Opposed sympathetic tone → Now stopped → Increased catecholamines → Dramatic Hypertension → Intense headache → Need gradual E (exit/taper). Use when recalling clonidine withdrawal complications. REBOUND = Receptor Upregulation + Unopposed During chronic clonidine: receptors upregulate (body compensates). At withdrawal: upregulated receptors unopposed → sympathetic surge → hypertension. Memory hook: 'Upregulated + Unopposed = Rebound.'
NBE Trap
NBE pairs 'clonidine withdrawal' with 'receptor upregulation' to trap students who confuse the mechanism (upregulation) with the clinical condition (rebound hypertension). Students may also conflate clonidine's known side effect during therapy (postural hypotension) with its withdrawal effect (hypertension), leading to option D.
Clinical Pearl
In Indian de-addiction programs, clonidine is commonly used off-label for opioid and alcohol withdrawal. Abrupt discontinuation is a real risk in non-compliant patients or when supply is interrupted. Recognizing rebound hypertension as a medical emergency—and counseling patients on the need for gradual tapering—is critical to prevent stroke or myocardial infarction in this vulnerable population.
_Reference: KD Tripathi Pharmacology Ch. 12 (Antihypertensives); Harrison Ch. 246 (Hypertension Management)_